Pfizer Ltd.
| BSE: 500680 | Sector: Health care |
| NSE: PFIZER | ISIN Code: INE182A01018 |
| BSE 00:00 | 27 Jun | 4105.00 |
2.70 (0.07%) |
OPEN
4100.00 |
HIGH
4137.65 |
LOW
4094.00 |
| NSE 00:00 | 27 Jun | 4111.55 |
12.25 (0.30%) |
OPEN
4147.00 |
HIGH
4147.00 |
LOW
4095.00 |
| OPEN | 4100.00 |
| PREVIOUS CLOSE | 4102.30 |
| VOLUME | 676 |
| 52-Week high | 6164.80 |
| 52-Week low | 4068.85 |
| P/E | 30.66 |
| Mkt Cap.(Rs cr) | 18,780 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Pfizer Ltd. (PFIZER) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 521.30 | -5.10 | -0.97 | 3112.91 |
| Cipla | 932.25 | -1.15 | -0.12 | 2468.28 |
| Dr Reddy's Labs | 4317.15 | 8.40 | 0.19 | 2186.40 |
| Sun Pharma.Inds. | 835.95 | 11.85 | 1.44 | 2139.70 |
| Divi's Lab. | 3673.50 | -6.90 | -0.19 | 1954.72 |
| Alkem Lab | 3032.40 | 28.55 | 0.95 | 1685.08 |
| Glenmark Pharma. | 386.45 | 2.70 | 0.70 | 1649.45 |
| Zydus Lifesci. | 353.90 | 0.20 | 0.06 | 1476.20 |
| Lupin | 629.90 | -0.05 | -0.01 | 1258.62 |
| Alembic Pharma | 748.95 | 22.85 | 3.15 | 1175.39 |
| Ipca Labs. | 911.85 | 22.90 | 2.58 | 1140.77 |
| Torrent Pharma. | 2860.60 | -14.90 | -0.52 | 1137.85 |
| Gland Pharma | 2658.60 | 14.90 | 0.56 | 997.01 |
| Sanofi India | 6436.75 | 26.75 | 0.42 | 944.40 |
| Laurus Labs | 467.05 | 0.45 | 0.10 | 750.09 |
| Abbott India | 17991.20 | -96.80 | -0.54 | 690.69 |
| Ajanta Pharma | 1263.95 | 14.10 | 1.13 | 675.64 |
| Wockhardt | 221.05 | -0.20 | -0.09 | 593.29 |
| Granules India | 267.90 | 11.25 | 4.38 | 552.78 |
| Pfizer | 4105.00 | 2.70 | 0.07 | 497.61 |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
